Zimmer Biomet Holdings (ZBH) Net Margin (2009 - 2026)

Zimmer Biomet Holdings' Net Margin history runs 18 years deep, the most recent figure standing at 11.42% for Q1 2026.

• On a quarterly basis, Net Margin rose 186.0% year-over-year to 11.42% in Q1 2026; TTM through Mar 2026 was 2.35%, a 404.0% decrease from a year earlier, with the FY2025 full-year figure at 3.08%, changed N/A from the prior year.
• Net Margin improved to 11.42% in Q1 2026 per ZBH's latest filing, from 36.56% in the prior quarter.
• Across five years, Net Margin topped out at 21.63% in Q4 2023 and bottomed at 36.56% in Q4 2025.
• The 5-year median for Net Margin is 10.39% (2023), against an average of 4.51%.
• Across the five-year window, Net Margin surged 1624 bps in 2023 and slumped 4856 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 3.54% in 2022, then jumped by 712 bps to 21.63% in 2023, then plunged by 224 bps to 26.92% in 2024, then slumped by 36 bps to 36.56% in 2025, then jumped by 131 bps to 11.42% in 2026.
• Per Business Quant, the three latest ZBH Net Margin figures stand at 11.42% (Q1 2026), 36.56% (Q4 2025), and 11.55% (Q3 2025).